Read review Dihexa for Autism Spectrum Disorder (ASD) The Campbell rs1858830 MET promoter C-allele autism finding (the strongest mechanistic anchor to Dihexa pharmacology), the January 2026 mGluR5 PET 16-23% lower availability, the December 2025 DAYBUE STIX (trofinetide) Rett approval, the March 2026 FDA leucovorin decision (CFD only, not autism), the 270,701 NHS open referrals breaching NICE NG142, and the ~700,000 UK autistic population
Recovery, body composition, and other goal-specific effects build over 2 to 3 months
People considering treatment should also understand the possible side effects of glutathione IV drip and discuss their medical history with a qualified doctor beforehand
Een voedingssupplement is geen vervanging voor een gevarieerde, evenwichtige voeding en een gezonde levensstijl
Pyridoxine is an inexpensive ingredient, and the additional compounding steps are straightforward